Venetoclax plus gilteritinib is effective in preclinical models of <i>FLT3</i> -mutant BCL11B-a lineage-ambiguous leukemiaLindsey E. Montefiori, Charles G. Mullighan, Qingsong Gao et al.|Blood|2025Cited by 7